|
Adagene Inc. (ADAG) DCF -Bewertung
CN | Healthcare | Biotechnology | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Adagene Inc. (ADAG) Bundle
Vereinfachen Sie die Bewertung der Adagene Inc. (ADAG) mit diesem anpassbaren DCF -Taschenrechner! Mit Real Adagene Inc. (ADAG) -Befinanzierungen und einstellbaren Prognoseeingaben können Sie Szenarien testen und Adagene Inc. (ADAG) in Minuten aufdecken.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .5 | .5 | 10.2 | 9.3 | 18.1 | 26.5 | 38.9 | 57.0 | 83.6 | 122.5 |
| Revenue Growth, % | 0 | 0 | 2019.85 | -8.67 | 94.9 | 46.56 | 46.56 | 46.56 | 46.56 | 46.56 |
| EBITDA | -15.5 | -41.3 | -70.0 | -77.4 | -15.0 | -25.6 | -37.5 | -55.0 | -80.6 | -118.2 |
| EBITDA, % | -3224.49 | -8611.81 | -687.82 | -832.8 | -82.55 | -96.51 | -96.51 | -96.51 | -96.51 | -96.51 |
| Depreciation | .8 | .9 | 1.1 | 1.4 | 1.2 | 12.4 | 18.1 | 26.6 | 39.0 | 57.1 |
| Depreciation, % | 170.14 | 178.83 | 11.06 | 15.38 | 6.67 | 46.62 | 46.62 | 46.62 | 46.62 | 46.62 |
| EBIT | -16.3 | -42.2 | -71.1 | -78.8 | -16.2 | -26.0 | -38.1 | -55.8 | -81.8 | -119.8 |
| EBIT, % | -3394.63 | -8790.65 | -698.88 | -848.18 | -89.22 | -97.84 | -97.84 | -97.84 | -97.84 | -97.84 |
| Total Cash | 100.5 | 75.2 | 174.4 | 143.8 | 109.9 | 26.5 | 38.9 | 57.0 | 83.6 | 122.5 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 2.1 | .1 | 7.5 | .6 | .2 | 11.1 | 16.3 | 23.9 | 35.0 | 51.2 |
| Account Receivables, % | 445.93 | 27.58 | 73.77 | 6.67 | 1.23 | 41.85 | 41.85 | 41.85 | 41.85 | 41.85 |
| Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 0.000208333333 | 0 | 0.000009827761 | 0 | 0 | 0.000043632219 | 0.000043632219 | 0.000043632219 | 0.000043632219 | 0.000043632219 |
| Accounts Payable | .7 | 1.8 | 3.3 | 3.7 | 3.1 | 15.4 | 22.5 | 33.0 | 48.3 | 70.8 |
| Accounts Payable, % | 148.48 | 377.08 | 32.64 | 39.45 | 17.08 | 57.84 | 57.84 | 57.84 | 57.84 | 57.84 |
| Capital Expenditure | -.2 | -.9 | -2.5 | -.7 | -.1 | -8.7 | -12.8 | -18.7 | -27.4 | -40.2 |
| Capital Expenditure, % | -31.63 | -194.83 | -24.67 | -7.44 | -0.46938 | -32.84 | -32.84 | -32.84 | -32.84 | -32.84 |
| Tax Rate, % | -9.8 | -9.8 | -9.8 | -9.8 | -9.8 | -9.8 | -9.8 | -9.8 | -9.8 | -9.8 |
| EBITAT | -17.1 | -42.2 | -72.8 | -79.3 | -17.7 | -26.0 | -38.1 | -55.8 | -81.8 | -119.8 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -17.9 | -39.2 | -80.1 | -71.3 | -16.8 | -20.9 | -30.7 | -45.0 | -66.0 | -96.7 |
| WACC, % | 6.19 | 6.19 | 6.19 | 6.19 | 6.19 | 6.19 | 6.19 | 6.19 | 6.19 | 6.19 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -208.1 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -99 | |||||||||
| Terminal Value | -2,353 | |||||||||
| Present Terminal Value | -1,743 | |||||||||
| Enterprise Value | -1,951 | |||||||||
| Net Debt | -88 | |||||||||
| Equity Value | -1,863 | |||||||||
| Diluted Shares Outstanding, MM | 44 | |||||||||
| Equity Value Per Share | -42.54 |
What You Will Get
- Pre-Filled Financial Model: Adagene Inc.’s actual data enables precise DCF valuation.
- Full Forecast Control: Adjust revenue growth, margins, WACC, and other key drivers.
- Instant Calculations: Automatic updates ensure you see results as you make changes.
- Investor-Ready Template: A refined Excel file designed for professional-grade valuation.
- Customizable and Reusable: Tailored for flexibility, allowing repeated use for detailed forecasts.
Key Features
- Comprehensive Data: Adagene Inc.'s historical financial reports and pre-filled projections.
- Customizable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
- Real-Time Results: Observe Adagene Inc.'s intrinsic value recalculated instantly.
- Intuitive Visual Outputs: Dashboard graphs present valuation results and essential metrics clearly.
- Designed for Precision: A professional-grade tool for analysts, investors, and finance professionals.
How It Functions
- Download the Template: Gain immediate access to the Excel-based ADAG DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and more.
- Instant Calculations: The model automatically updates Adagene Inc.'s intrinsic value.
- Test Scenarios: Experiment with different assumptions to assess potential valuation changes.
- Analyze and Decide: Utilize the results to inform your investment or financial analysis.
Why Choose This Calculator?
- User-Friendly Interface: Perfect for both novices and seasoned professionals.
- Customizable Inputs: Adjust parameters to tailor the analysis to your needs.
- Real-Time Feedback: Watch as Adagene Inc.'s valuation updates instantly with your changes.
- Plug-and-Play: Comes preloaded with Adagene Inc.'s (ADAG) latest financial metrics for immediate insights.
- Relied Upon by Experts: A go-to tool for investors and analysts aiming for well-informed choices.
Who Should Use This Product?
- Individual Investors: Make informed decisions about buying or selling Adagene Inc. (ADAG) stock.
- Financial Analysts: Streamline valuation processes with ready-to-use financial models for Adagene Inc. (ADAG).
- Consultants: Deliver professional valuation insights on Adagene Inc. (ADAG) to clients quickly and accurately.
- Business Owners: Understand how biotech companies like Adagene Inc. (ADAG) are valued to guide your own strategy.
- Finance Students: Learn valuation techniques using real-world data and scenarios related to Adagene Inc. (ADAG).
What the Template Contains
- Historical Data: Includes Adagene Inc.'s (ADAG) past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate Adagene Inc.'s (ADAG) intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of Adagene Inc.'s (ADAG) financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.